Company Overview

Update
Founded:
April 6, 1999
Headquarters:
London
IPO:
Went Public on May 21, 1993
Stock:
NYSE:AZN
Categories:
Biotechnology, Medical, Pharmaceuticals, See All (4)

AstraZeneca, a global pharmaceutical company, discovers, develops, manufactures and markets prescription medicines.

Description

Update

AstraZeneca is global innovation-driven biopharmaceutical company specialising in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference in healthcare.

AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of taking the treatment. They also focus on getting the best from every medicine they make by exploring all the ways it can be used or improved.

Their business strategy sets out their path to success in delivering great medicines to patients through innovative science and global excellence in development and commercialisation.

Current Team (12)

Update

Board Members and Advisors (10)

Update
  • 458a447478b43d5adade352746e7edcc

    Leif Johansson

    Non-Executive Chairman, Chairman of the Nomination and Governance Committee, member of the Remuneration Committee
  • 1677ed78b46508800cecc90195fef2ad

    John Varley

    Senior Non-Executive Director Chairman of the Remuneration Committee, member of the Nomination and Governance Committee
  • Daf4a3bdf6eff0368a4345d5ec562885

    Marcus Wallenberg

    Non-Executive Director Member of the Science Committee
  • 730b4c3e19616e58ec5a9d5a77c91bce

    Dame Nancy Rothwell

    Non-Executive Director Chairman of the Science Committee, member of the Remuneration Committee, member of the Nomination and Governance Committee
  • D3438fed2f019b67e270a5a79b0d0ae2

    Bruce Burlington

    Non-Executive Director Member of the Science Committee, member of the Audit Committee
  • C70a3502c18534389b08327f715ed543

    Baroness Shriti Vadera

    Non-Executive Director and member of the Audit Committee
  • Ae75601d59561024412461d0e1850f90

    Rudy Markham

    Non-Executive Director Chairman of the Audit Committee, member of the Remuneration Committee, member of the Nomination and Governance Committee
  • Ff1fc61b6589b7954c005c9b8f861ae2

    Jean-Philippe Courtois

    Non-Executive Director Member of the Audit Committee

Investments (16)

Update

Acquisitions (5)

Update

Offices/Locations (1)

Update
  • HQ

    15 Stanhope Gate

    London, W1K 1LN

    GBR

Images (1)

Update
  • 78340f2d0dc1428154888f981ba674fa